BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18372392)

  • 21. Gene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells.
    Pandey AK; Munjal N; Datta M
    PLoS One; 2010 Feb; 5(2):e9063. PubMed ID: 20140224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders.
    Fisher-Wellman K; Bell HK; Bloomer RJ
    Oxid Med Cell Longev; 2009; 2(1):43-51. PubMed ID: 20046644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia.
    Gutierrez DA; Puglisi MJ; Hasty AH
    Curr Diab Rep; 2009 Feb; 9(1):26-32. PubMed ID: 19192421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
    Qin B; Dawson H; Anderson RA
    Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
    Jin UH; Kang YJ; Chang YC; Kim CH
    J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
    Qin B; Qiu W; Avramoglu RK; Adeli K
    Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid and lipoprotein dysregulation in insulin resistant states.
    Avramoglu RK; Basciano H; Adeli K
    Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise.
    Lavoie JM; Gauthier MS
    Cell Mol Life Sci; 2006 Jun; 63(12):1393-409. PubMed ID: 16649140
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.